CHINOOK THERAPEUTICS XXX
COM · CUSIP 169CVR016
4
institutional holders
+0 vs Q1 2024
536.5k
shares reported held*
$129.8kreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $103 (-403 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.24.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 2 |
| Q4 2023 | 4 |
| Q1 2024 | 4 |
| Q2 2024 | 4 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 1 | 0 |
| Q1 2024 | 0 | 0 |
| Q2 2024 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| RHUMBLINE ADVISERS | Reduced | -403 |
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Erste Asset Management GmbH 0.00% of their portfolio | 307.8k $120.0k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 89.4k $0 | Reduced -403 |
| Propel Bio Management, LLC 0.01% of their portfolio | 79.4k $9.8k | Unchanged |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 0.00% of their portfolio | 60.0k $0 | Unchanged |